Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome

There is some evidence that the efficacy of metformin as an ovulation stimulation agent depends on the body mass index (BMI) of the treated anovulatory women with polycystic ovary syndrome (PCOS). The aim of this study was to examine the likelihood of successful ovulation among obese (BMI ⩾30kg/m2)...

Full description

Saved in:
Bibliographic Details
Published in:Saudi pharmaceutical journal 2017-07, Vol.25 (5), p.795-800
Main Authors: Al-Ruthia, Yazed Sulaiman, Al-Mandeel, Hazem, AlSanawi, Hisham, Mansy, Wael, AlGasem, Reem, AlMutairi, Lama
Format: Article
Language:English
Subjects:
Body mass index
Induction
Metformin
Obesity
Original
Ovulation
Polycystic ovary syndrome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is some evidence that the efficacy of metformin as an ovulation stimulation agent depends on the body mass index (BMI) of the treated anovulatory women with polycystic ovary syndrome (PCOS). The aim of this study was to examine the likelihood of successful ovulation among obese (BMI ⩾30kg/m2) versus non-obese (BMI
ISSN:1319-0164
2213-7475
DOI:10.1016/j.jsps.2016.12.001